825 related articles for article (PubMed ID: 17400294)
1. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
[TBL] [Abstract][Full Text] [Related]
2. Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Kondo N; Honda S; Ishibashi K; Tsukahara Y; Negi A
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1101-5. PubMed ID: 18326737
[TBL] [Abstract][Full Text] [Related]
3. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
[TBL] [Abstract][Full Text] [Related]
4. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability.
Sasahara M; Tsujikawa A; Musashi K; Gotoh N; Otani A; Mandai M; Yoshimura N
Am J Ophthalmol; 2006 Oct; 142(4):601-7. PubMed ID: 17011852
[TBL] [Abstract][Full Text] [Related]
5. Polypoidal choroidal vasculopathy in Taiwanese patients.
Chang YC; Wu WC
Ophthalmic Surg Lasers Imaging; 2009; 40(6):576-81. PubMed ID: 19928723
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization.
Hogg RE; Woodside JV; Gilchrist SE; Graydon R; Fletcher AE; Chan W; Knox A; Cartmill B; Chakravarthy U
Ophthalmology; 2008 Jun; 115(6):1046-1052.e2. PubMed ID: 17953990
[TBL] [Abstract][Full Text] [Related]
7. [Polypoidal choroidal vasculopathy--a rare form of choroidal neovascularization].
Weglarz M; Karska-Basta I; Kubicka-Trzaska A; Romanowska-Dixon B
Klin Oczna; 2009; 111(4-6):145-8. PubMed ID: 19673446
[TBL] [Abstract][Full Text] [Related]
8. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography.
Kang SW; Chung SE; Shin WJ; Lee JH
Br J Ophthalmol; 2009 Jun; 93(6):759-64. PubMed ID: 19304584
[TBL] [Abstract][Full Text] [Related]
9. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration.
Chung SE; Kang SW; Lee JH; Kim YT
Ophthalmology; 2011 May; 118(5):840-5. PubMed ID: 21211846
[TBL] [Abstract][Full Text] [Related]
10. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H
Retina; 2009; 29(7):960-5. PubMed ID: 19491727
[TBL] [Abstract][Full Text] [Related]
11. Fundus autofluorescence in polypoidal choroidal vasculopathy.
Yamagishi T; Koizumi H; Yamazaki T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1650-7. PubMed ID: 22512987
[TBL] [Abstract][Full Text] [Related]
12. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
Tong JP; Chan WM; Liu DT; Lai TY; Choy KW; Pang CP; Lam DS
Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490
[TBL] [Abstract][Full Text] [Related]
13. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
[TBL] [Abstract][Full Text] [Related]
14. The fundoscopic features for differentiation between polypoidal choroidal vasculopathy and choroidal neovascularization from age-related macular degeneration.
Ampornpruet A; Ruamviboonsuk P; Kokekhuntod S
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S51-6. PubMed ID: 16681052
[TBL] [Abstract][Full Text] [Related]
15. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
Sakurada Y; Nakamura Y; Yoneyama S; Mabuchi F; Gotoh T; Tateno Y; Sugiyama A; Kubota T; Iijima H
Ophthalmic Res; 2015; 53(1):2-7. PubMed ID: 25472810
[TBL] [Abstract][Full Text] [Related]
16. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration.
Hayashi H; Yamashiro K; Tsujikawa A; Ota M; Otani A; Yoshimura N
Am J Ophthalmol; 2009 Jul; 148(1):83-9.e1. PubMed ID: 19327745
[TBL] [Abstract][Full Text] [Related]
17. Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population.
Nakata I; Yamashiro K; Yamada R; Gotoh N; Nakanishi H; Hayashi H; Akagi-Kurashige Y; Tsujikawa A; Otani A; Saito M; Iida T; Oishi A; Matsuo K; Tajima K; Matsuda F; Yoshimura N
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):794-8. PubMed ID: 22232432
[TBL] [Abstract][Full Text] [Related]
18. Associations of the C2-CFB-RDBP-SKIV2L locus with age-related macular degeneration and polypoidal choroidal vasculopathy.
Liu K; Chen LJ; Tam PO; Shi Y; Lai TY; Liu DT; Chiang SW; Yang M; Yang Z; Pang CP
Ophthalmology; 2013 Apr; 120(4):837-43. PubMed ID: 23260260
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.
Honda S; Imai H; Yamashiro K; Kurimoto Y; Kanamori-Matsui N; Kagotani Y; Tamura Y; Yamamoto H; Ohoto S; Takagi H; Uenishi M; Negi A
Ophthalmologica; 2009; 223(5):333-8. PubMed ID: 19478533
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration.
Gotoh N; Kuroiwa S; Kikuchi T; Arai J; Arai S; Yoshida N; Yoshimura N
Am J Ophthalmol; 2004 Oct; 138(4):567-73. PubMed ID: 15488782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
